Gotham Makker

All filings by Gotham Makker on record concern Rocket Pharmaceuticals, Inc., in the capacity of board member. The record holds 7 filings, for trades running from 16 June 2021 to 18 June 2025.

Sales make up the whole of the open-market record (5 sales, €16.2M). Outside the open market, there are 1 share grant.

The latest filing, published on 18 July 2025, reports a share grant in Rocket Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.